Summary. Glucagon in concentrations similar to those found in human plasma markedly stimulates lipolysis in rat adipose tissue in vitro. The effects of these "physiological" concentrations of glucagon are reduced or abolished by insulin at concentrations of 25 and 100 ~U/ml. Considering the marked insulinogenic effect of glucagon these observations may provide an explanation for the delayed increase of blood FFA observed after glucagon injection in vivo.
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Effet de l'insuline sur la llpolyse induite par le glucagon in vitro
Rdsumg. A des concentrations proches de celles qui sont rencontrdes dans le plasma humain, le glucagon stimule fortement la lipolyse au niveau de la graisse 4pididymaire du rat, dtudide in vitro. Les Recently, attention has been drawn to the interactions between glueagon and insulin : glucagon is a potent stimulus of insulin release both in vivo [t6, 1, 9] and in vitro [22, 20] , and since the oral ingestion of glucose increases the level of glucagon or a "glueagonlike material" in the blood [17, 6] , it has been suggested that glucagon may be one of the mediators of insulin secretion after glucose feeding.
On the other hand, glucagon and insulin have clearly opposite effects on adipose tissue metabolism : glucagon is strongly lipolytic [3, 23, 8] , whereas insulin reduces lipolysis even in the absence of glucose [5, 2] .
It has been claimed that insulin does not reduce the lipolytic action of glucagon on isolated fat cells of the rat [2] , but in these experiments the concentrations of glueagon tested were 10 to 150 times greater than those found in normal peripheral plasma by immunoassay [17, 6, 21, 15, 11] . On the other hand, using submaxireal but still high concentrations of glucagon, RODBE~ and JONES [14] demonstrated an inhibitory action of small concentrations of insulin on the release of fatty acids and glycerol by isolated fat cells. Since glucagon enhances lipolysis at very low concentrations, the present experiments were designed to study the antilipolytic effect of "physiological" concentrations of insulin on the stimulation of lipolysis by "physiological" concentrations of glucagon. * This work was supported by the "Fonds National de la Recherche Seientifique" and the "Fonds de la Recherche Scientifique Mddicale", Belgium.
Material and Methods
Male albino rats of the Wistar strain, weighing 160--180 g and fasted 12--14 h were used. The animals were killed by decapitation, and the epididymal fad pads were removed rapidly according to the technique of R~NOLD eta]. [13] . Pieces of tissue weighing 120--140 mg were incubated for 4 h in 4 ml of a modified [13] Krebs-Ringer bicarbonate buffer containing 3% human albumin (Fraction V, Armour Co). Glucose was present at the concentration of 100 or 300 rag%. Ten times recrystallized, bovine insulin and cystein-treated glucagon (insulin contamination 0.002%) were obtained through the courtesy of Dr. SC~LICH~K~V~, I~OVO Industri A.S. Copenhagen, Denmark, and used at the concentrations of 0, 25, and 100 ~U/ml, and of 0, 0.002, 0.005 and 0.010 ~g/ml, respectively. Aliquots of the medium were taken for glycerol analysis by an enzymatic procedure [4] .
Results
The results are summarized in Tables 1 and 2. 1. In the presence of glucose at a concentration of 100 rag% and in the absence of insulin, concentrations as small as 0.002 ~g/ml of glueagon stimulated lipolysis as tested by glycerol release. This stimulating effect of glucagon was reduced by insulin at a concentration of 25 ~U/ml. At this concentration the effect of 0.002 9g/ml of glucagon was abolished; the effects of 0.005 and 0.010 ~g/ml, although reduced, remained statisti-P, J. LEFEBVI~E and A.S. LuYcKX: Effect of Insulin Diabetologia cally significant. At the concentration of 100 ~U/ml, insulin abolished the effect of giucagon at all concentrations tested. 2. In the presence of glucose at a concentration of 300 rag%, giucagon enhanced lipolysis when added in concentrations of 0.005 and 0.010 ~g/ml. These concentrations remained effective even in the presence of 25 or 100 ~U/ml of insulin, although the effect was reduced.
Discussion
It is still hazardous to define the normal range of plasma giucagon concentration levels on the basis of the available data obtained by radioimmunoassay [19] . It has been reported that basal levels in man range from 200 ~g Eq/ml to 8000 ~g Eq/ml [17, 6, 21, 15, 11, 18] , with most values between 500 and 2000 ~g Eq/ml. Values up to 20000 ~g Eq/ml have been reported in various clinical conditions [6] , and very high values of 36000 and 55000 tz~g Eq/ml have been observed in a case of giucagonoma [12] .
The present data indicate that concentrations of glucagon comparable with the concentrations of the hormone found in human plasma [recent data obtained using an antiserum "discriminating" pancreatic glucagon and gut glucagon-like immunoreactivity indicate that true concentrations of pancreatic giucagon in peripheral human plasma could be in the range of 200 to 300 y.gEq/ml (UNG~, 1968, and H~DI~G, 1968, personal communications)] markedly stimulate Hpolysis in incubated rat adipose tissue. The data also show that "physiological" concentrations of insulin (i. e. 25 and 100 ~U/ml) are able to reduce or abolish the lipolytic effects of these concentrations of glucagon. These results are not consistent with those obtained by other workers [2] using much higher concentrations of glucagon. A reduction of the Hpolytic effect of glucagon has also been observed by increasing the concentration of glucose in the incubation medium from 100 to 300 mg per cent.
These observations, correlated with the potent insulinogenic effect of glucagon, may provide an explanation for the delayed increase of blood free fatty acids observed after giucagon injection in man [10, 7] , as well as in the dog [8] . It is possible that the lipolytic properties of giucagon injected in vivo can only be observed after the maximum hypergiycaemia and hyperinsulinaemia have subsided. However, it remains to be demonstrated that giucagon injected intravenously or intramuscularely, still exerts a lipolytie effect 2 to 4 h after its injection, when the increase in blood FFA is observed.
